Does fish oil have an anti-obesity effect in overweight/obese adults? A meta-analysis of randomized controlled trials

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Du, Shichun ^a   Jin, Jie ^a   Fang, Wenjun ^a   Su, Qing ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID; ANTIOBESITY AGENT;

ANTIOBESITY ACTIVITY; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; DRUG ACTIVITY; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS; OBESITY; SUPPLEMENTATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; DIETARY SUPPLEMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; BODY MASS INDEX; DIETARY SUPPLEMENTS; FISH OILS; HUMANS; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84956622386     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142652     Document Type: Article

References (70)

1. Janovska P, Flachs P, Kazdova L, Kopecky J. Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis. Physiological research/Academia Scientiarum Bohemoslovaca. 2013; 62(2):153-61. PMID: 23234412.
2. Perez-Matute P, Perez-Echarri N, Martinez JA, Marti A, Moreno-Aliaga MJ. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. The British journal of nutrition. 2007; 97(2):389-98. doi: 10.1017/S0007114507207627 PMID: 17298710.
3. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia. 2006; 49(2):394-7. doi: 10.1007/s00125-005-0053-y PMID: 16397791.
4. Perez-Echarri N, Perez-Matute P, Marcos-Gomez B, Martinez JA, Moreno-Aliaga MJ. Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats. The British journal of nutrition. 2009; 101(7):1059-67. doi: 10.1017/S0007114508048307 PMID: 18755047.
5. Wakutsu M, Tsunoda N, Mochi Y, Numajiri M, Shiba S, Muraki E, et al. Improvement in the high-fat dietinduced dyslipidemia and adiponectin levels by fish oil feeding combined with food restriction in obese KKAy mice. Bioscience, biotechnology, and biochemistry. 2012; 76(5):1011-4. doi: 10.1271/bbb. 110743 PMID: 22738976.
6. Haugaard SB, Madsbad S, Hoy CE, Vaag A. Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clinical endocrinology. 2006; 64(2):169-78. doi: 10.1111/j.1365-2265.2006.02444.x PMID: 16430716.
7. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. Atherosclerosis. 2006; 184(2):237-46. doi: 10.1016/j.atherosclerosis.2005.06.042 PMID: 16084516.
8. Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, et al. Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes care. 2010; 33(1):197-9. doi: 10.2337/dc09-1235 PMID: 19841042; PubMed Central PMCID: PMC2797972.
9. Moore CS, Bryant SP, Mishra GD, Krebs JD, Browning LM, Miller GJ, et al. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women. Nutrition. 2006; 22 (10):1012-24. doi: 10.1016/j.nut.2006.07.005 PMID: 17027436.
10. Raatz SK, Rosenberger TA, Johnson LK, Wolters WW, Burr GS, Picklo MJ Sr. Dose-dependent consumption of farmed Atlantic salmon (Salmo salar) increases plasma phospholipid n-3 fatty acids differentially. Journal of the Academy of Nutrition and Dietetics. 2013; 113(2):282-7. doi: 10.1016/j.jand. 2012.09.022 PMID: 23351633; PubMed Central PMCID: PMC3572904.
11. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. Journal of clinical epidemiology. 2010; 63(8):e1-37. doi: 10.1016/j.jclinepi.2010.03.004 PMID: 20346624.
12. Jadad AR, McQuay HJ. Meta-analyses to evaluate analgesic interventions: a systematic qualitative review of their methodology. Journal of clinical epidemiology. 1996; 49(2):235-43. PMID: 8606325.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003; 327(7414):557-60. doi: 10.1136/bmj.327.7414.557 PMID: 12958120; PubMed Central PMCID: PMC192859.
14. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. Bmj. 1997; 315 (7121):1533-7. PMID: 9432252; PubMed Central PMCID: PMC2127925.
15. Cussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. The Journal of clinical endocrinology and metabolism. 2009; 94(10):3842-8. doi: 10.1210/jc.2009-0870 PMID: 19622617.
16. DeFina LF, Marcoux LG, Devers SM, Cleaver JP, Willis BL. Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. The American journal of clinical nutrition. 2011; 93(2):455-62. doi: 10.3945/ajcn.110.002741 PMID: 21159785.
17. Gammelmark A, Madsen T, Varming K, Lundbye-Christensen S, Schmidt EB. Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects. Nutrition research. 2012; 32(1):15-23. doi: 10.1016/j.nutres.2011.12.007 PMID: 22260859.
18. Hill AM, Buckley JD, Murphy KJ, Howe PR. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. The American journal of clinical nutrition. 2007; 85(5):1267-74. PMID: 17490962.
19. Itariu BK, Zeyda M, Hochbrugger EE, Neuhofer A, Prager G, Schindler K, et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. The American journal of clinical nutrition. 2012; 96(5):1137-49. doi: 10.3945/ajcn.112. 037432 PMID: 23034965.
20. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arteriosclerosis, thrombosis, and vascular biology. 2007; 27(9):1918-25. doi: 10.1161/ATVBAHA.106.136853 PMID: 17569885.
21. Crochemore IC, Souza AF, de Souza AC, Rosado EL. omega-3 polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity. Nutrition in clinical practice: official publication of the American Society for Parenteral and Enteral Nutrition. 2012; 27(4):553-60. doi: 10.1177/0884533612444535 PMID: 22661243.
22. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. The American journal of clinical nutrition. 2007; 86(6):1670-9. PMID: 18065585.
23. Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS. Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. The American journal of clinical nutrition. 2008; 87 (2):347-53. PMID: 18258624; PubMed Central PMCID: PMC2265085.
24. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, et al. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. International journal of obesity. 2006; 30(10):1535-44. doi: 10.1038/sj.ijo.0803309 PMID: 16552404.
25. Mendez-Sanchez N, Gonzalez V, Aguayo P, Sanchez JM, Tanimoto MA, Elizondo J, et al. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. The Journal of nutrition. 2001; 131(9):2300-3. PMID: 11533270.
26. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. The American journal of clinical nutrition. 1999; 70(5):817-25. PMID: 10539741.
27. Munro IA, Garg ML. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults. Obesity research & clinical practice. 2013; 7(3):e173-81. doi: 10.1016/j. orcp.2011.11.001 PMID: 23697585.
28. Rafraf M, Mohammadi E, Asghari-Jafarabadi M, Farzadi L. Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. Journal of the American College of Nutrition. 2012; 31(5):361-8. PMID: 23529993.
29. Sjoberg NJ, Milte CM, Buckley JD, Howe PR, Coates AM, Saint DA. Dose-dependent increases in heart rate variability and arterial compliance in overweight and obese adults with DHA-rich fish oil supplementation. The British journal of nutrition. 2010; 103(2):243-8. doi: 10.1017/S000711450999153X PMID: 19664302.
30. Thorsdottir I, Tomasson H, Gunnarsdottir I, Gisladottir E, Kiely M, Parra MD, et al. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. International journal of obesity. 2007; 31(10):1560-6. doi: 10.1038/sj.ijo.0803643 PMID: 17502874.
31. Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome - LIPGENE: a European randomized dietary intervention study. International journal of obesity. 2011; 35(6):800-9. doi: 10.1038/ijo.2010.209 PMID: 20938439.
32. Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism: clinical and experimental. 2011; 60(12):1711-8. doi: 10.1016/j.metabol.2011.04.007 PMID: 21640360; PubMed Central PMCID: PMC3210884.
33. Wong AT, Chan DC, Barrett PH, Adams LA, Watts GF. Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet. The Journal of nutrition. 2013; 143(4):437-41. doi: 10.3945/jn.112.169359 PMID: 23365106.
34. Hartwich J, Malec MM, Partyka L, Perez-Martinez P, Marin C, Lopez-Miranda J, et al. The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation - insights from the LIPGENE study. Clinical nutrition. 2009; 28(5):510-5. doi: 10.1016/j.clnu.2009.04.016 PMID: 19481310.
35. Chan DC, Watts GF, Barrett PH, Beilin LJ, Redgrave TG, Mori TA. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. Diabetes. 2002; 51(8):2377-86. PMID: 12145148.
36. Warner JG Jr., Ullrich IH, Albrink MJ, Yeater RA. Combined effects of aerobic exercise and omega-3 fatty acids in hyperlipidemic persons. Medicine and science in sports and exercise. 1989; 21(5):498-505. PMID: 2691812.
37. Neale EP, Muhlhausler B, Probst YC, Batterham MJ, Fernandez F, Tapsell LC. Short-term effects of fish and fish oil consumption on total and high molecular weight adiponectin levels in overweight and obese adults. Metabolism: clinical and experimental. 2013; 62(5):651-60. doi: 10.1016/j.metabol.2012. 10.014 PMID: 23190874.
38. Sneddon AA, Tsofliou F, Fyfe CL, Matheson I, Jackson DM, Horgan G, et al. Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin. Obesity. 2008; 16 (5):1019-24. doi: 10.1038/oby.2008.41 PMID: 18356842.
39. Kriketos AD, Robertson RM, Sharp TA, Drougas H, Reed GW, Storlien LH, et al. Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects. Journal of hypertension. 2001; 19(10):1745-54. PMID: 11593093.
40. Kunesova M, Braunerova R, Hlavaty P, Tvrzicka E, Stankova B, Skrha J, et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiological research/Academia Scientiarum Bohemoslovaca. 2006; 55(1):63-72. PMID: 15857162.
41. Hlavaty P, Kunesova M, Gojova M, Tvrzicka E, Vecka M, Roubal P, et al. Change in fatty acid composition of serum lipids in obese females after short-term weight-reducing regimen with the addition of n-3 long chain polyunsaturated fatty acids in comparison to controls. Physiological research/Academia Scientiarum Bohemoslovaca. 2008; 57 Suppl 1:S57-65. PMID: 18271691.
42. Vasickova L, Stavek P, Suchanek P. Possible effect of DHA intake on body weight reduction and lipid metabolism in obese children. Neuro endocrinology letters. 2011; 32 Suppl 2:64-7. PMID: 22101886.
43. Lopez-Alarcon M, Martinez-Coronado A, Velarde-Castro O, Rendon-Macias E, Fernandez J. Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children. Archives of medical research. 2011; 42(6):502-8. doi: 10.1016/j.arcmed.2011.06.010 PMID: 22136960.
44. Dangardt F, Osika W, Chen Y, Nilsson U, Gan LM, Gronowitz E, et al. Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents. Atherosclerosis. 2010; 212(2):580-5. doi: 10.1016/j.atherosclerosis.2010.06.046 PMID: 20727522.
45. Bourque C, St-Onge MP, Papamandjaris AA, Cohn JS, Jones PJ. Consumption of an oil composed of medium chain triacyglycerols, phytosterols, andN-3 fatty acids improves cardiovascular risk profile in overweight women. Metabolism: clinical and experimental. 2003; 52(6):771-7. PMID: 12800105.
46. Bragt MC, Mensink RP. Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2012; 22 (11):966-73. doi: 10.1016/j.numecd.2010.12.010 PMID: 21429719.
47. Chan DC, Nguyen MN, Watts GF, Ooi EM, Barrett PH. Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity. The American journal of clinical nutrition. 2010; 91(4):900-6. doi: 10.3945/ajcn.2009.28422 PMID: 20181806.
48. Neff LM, Culiner J, Cunningham-Rundles S, Seidman C, Meehan D, Maturi J, et al. Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. The Journal of nutrition. 2011; 141(2):207-13. doi: 10.3945/jn.110.130021 PMID: 21178084; PubMed Central PMCID: PMC3021440.
49. Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis. 2008; 200 (1):135-40. doi: 10.1016/j.atherosclerosis.2008.06.003 PMID: 18667204.
50. Berge K, Piscitelli F, Hoem N, Silvestri C, Meyer I, Banni S, et al. Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. Lipids in health and disease. 2013; 12:78. doi: 10.1186/1476-511X-12-78 PMID: 23706001; PubMed Central PMCID: PMC3680309.
51. Harden CJ, Dible VA, Russell JM, Garaiova I, Plummer SF, Barker ME, et al. Long-chain polyunsaturated fatty acid supplementation had no effect on body weight but reduced energy intake in overweight and obese women. Nutrition research. 2014; 34(1):17-24. doi: 10.1016/j.nutres.2013.10.004 PMID: 24418242.
52. Munro IA, Garg ML. Prior supplementation with long chain omega-3 polyunsaturated fatty acids promotes weight loss in obese adults: a double-blinded randomised controlled trial. Food & function. 2013; 4(4):650-8. doi: 10.1039/c3fo60038f PMID: 23396496.
53. Lohner S, Fekete K, Marosvolgyi T, Decsi T. Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Annals of nutrition & metabolism. 2013; 62(2):98-112. doi: 10.1159/000345599 PMID: 23327902.
54. Micallef M, Munro I, Phang M, Garg M. Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity. The British journal of nutrition. 2009; 102(9):1370-4. doi: 10.1017/S0007114509382173 PMID: 19454127.
55. Karlsson M, Marild S, Brandberg J, Lonn L, Friberg P, Strandvik B. Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents. Obesity. 2006; 14(11):1931-9. doi: 10.1038/oby.2006.225 PMID: 17135608.
56. Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 1997; 21(8):637-43. PMID: 15481762.
57. Jakobsen MU, Dethlefsen C, Due KM, Slimani N, Chajes V, May AM, et al. Plasma phospholipid longchain n-3 polyunsaturated fatty acids and body weight change. Obesity facts. 2011; 4(4):312-8. doi: 10.1159/000330710 PMID: 21921655.
58. Garaulet M, Perez-Llamas F, Perez-Ayala M, Martinez P, de Medina FS, Tebar FJ, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. The American journal of clinical nutrition. 2001; 74(5):585-91. PMID: 11684525.
59. Garaulet M, Hernandez-Morante JJ, Tebar FJ, Zamora S. Anthropometric indexes for visceral fat estimation in overweight/obese women attending to age and menopausal status. Journal of physiology and biochemistry. 2006; 62(4):245-52. PMID: 17615950.
60. Matsumura K. [Effects of eicosapentaenoic acid on visceral fat and heart rate variability: assessment by power spectral analysis]. Journal of cardiology. 2007; 50(4):243-51. PMID: 17987840.
61. Janczyk W, Socha P, Lebensztejn D, Wierzbicka A, Mazur A, Neuhoff-Murawska J, et al. Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial. BMC pediatrics. 2013; 13:85. doi: 10.1186/1471-2431-13-85 PMID: 23702094; PubMed Central PMCID: PMC3672084.
62. Sofi F, Giangrandi I, Cesari F, Corsani I, Abbate R, Gensini GF, et al. Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study. International journal of food sciences and nutrition. 2010; 61(8):792-802. doi: 10.3109/09637486.2010.487480 PMID: 20465434.
63. Hatzitolios A, Savopoulos C, Lazaraki G, Sidiropoulos I, Haritanti P, Lefkopoulos A, et al. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology. 2004; 23 (4):131-4. PMID: 15333967.
64. Bouzianas DG, Bouziana SD, Hatzitolios AI. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutrition reviews. 2013; 71(11):753-71. doi: 10.1111/nure.12073 PMID: 24148001.
65. Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P. The therapeutic potential of longchain omega-3 fatty acids in nonalcoholic fatty liver disease. Clinical nutrition. 2011; 30(1):6-19. doi: 10.1016/j.clnu.2010.06.001 PMID: 20619513.
66. Harris WS, Zucker ML, Dujovne CA. Omega-3 fatty acids in hypertriglyceridemic patients: triglycerides vs methyl esters. The American journal of clinical nutrition. 1988; 48(4):992-7. PMID: 3421209.
67. Deck C, Radack K. Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial. Archives of internal medicine. 1989; 149(8):1857-62. PMID: 2669667.
68. Buckley JD, Howe PR. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obesity reviews: an official journal of the International Association for the Study of Obesity. 2009; 10(6):648-59. doi: 10.1111/j.1467-789X.2009.00584.x PMID: 19460115.
69. Buckley JD, Howe PR. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity - a review. Nutrients. 2010; 2(12):1212-30. doi: 10.3390/nu2121212 PMID: 22254005; PubMed Central PMCID: PMC3257626.
70. Tapsell LC, Batterham MJ, Charlton KE, Neale EP, Probst YC, O'Shea JE, et al. Foods, nutrients or whole diets: effects of targeting fish and LCn3PUFA consumption in a 12mo weight loss trial. BMC public health. 2013; 13:1231. doi: 10.1186/1471-2458-13-1231 PMID: 24369765; PubMed Central PMCID: PMC3890608.